The Centers for Medicare & Medicaid Services’ Hospital Price Transparency final rule goes into effect on Jan. 1, 2021. The AHA and three other national organizations sued the federal government challenging the final rule. The case is pending in a federal appeals court.
Member
The AHA today released legislative advisories on a 340B bill introduced by a bipartisan House working group and a legislative discussion draft introduced in the Senate.
On June 29, Sen. Bill Cassidy, R-La., unveiled a legislative discussion draft titled the 340B Drug Pricing Integrity and Affordability for Patients Act.
Reps. Scott Peters, D-Calif., and John Joyce, R-Pa., introduced the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, or SECURE 340B Act.
H-ISAC TLP Green: Daily Cyber Headlines - July 8, 2026.
A daily ransomware tracker at TLP Green to increase awareness of the ransomware threat.
If you haven’t done so yet, please register for an AHA 340B Advocacy Alliance call on July 8 at 3 p.m. ET to hear the latest updates on the 340B Drug Pricing Program.
The Centers for Medicare & Medicaid Services (CMS) July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system (PPS) rates by a net 2.4% in calendar year (CY) 2027 compared to CY 2026.
The Centers for Medicare & Medicaid Services (CMS) July 1 issued its calendar year (CY) 2027 proposed rule for the home health (HH) prospective payment system (PPS). This regulatory advisory reviews highlights of this rule. CMS will accept comments on the HH proposed rule until Aug. 31.
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system payments by 2.4% in calendar year 2027 compared to CY 2026.